Report - Research Letter - NATAP Letter AIDS 2015, 29:853–856 Switch to maraviroc/raltegravir dual therapy leads ... MIP-1β MIG IP-10 MCP-1 IL-18 IL-6 sCD163*sCD14* 2000 1800 1600 1400

Please pass captcha verification before submit form